Pediatric Hereditary Polyposis Syndromes: Diagnosis, Surveillance, and Management Across Evolving Guidelines

Hussein Khalifeh1, Xiaoyi Zhang1, Brett J Hoskins2,3

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children at IU Health, Indianapolis, IN, USA.

Insights

Pediatric hereditary polyposis syndrome management requires lifelong surveillance. Synthesizing guidelines can improve care consistency, though implementation gaps persist.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Genetics
  • Hereditary Cancer Syndromes

Background:

  • Lifelong surveillance and multidisciplinary care are crucial for pediatric hereditary polyposis syndromes.
  • Pediatric care for these syndromes shows significant variability despite evolving guidelines.

Purpose of the Study:

  • To synthesize current society recommendations for pediatric hereditary polyposis syndromes.
  • To contextualize guideline implementation within pediatric clinical practice.

Main Methods:

  • A narrative review of current literature and major hereditary polyposis guideline frameworks.
  • Emphasis on pediatric considerations for familial adenomatous polyposis (FAP), juvenile polyposis syndrome (JPS), Peutz-Jeghers syndrome (PJS), and other rare syndromes.

Main Results:

  • Guidelines generally agree on syndrome-directed surveillance but vary in pediatric specificity, initiation age, and intervals.
  • Key pediatric distinctions include specific screenings (e.g., hepatoblastoma, HHT) and early small-bowel surveillance for PJS.
  • Implementation gaps exist in managing genotype-negative disease, surgical referral timing, endoscopy use, and transition to adult care.

Conclusions:

  • An integrated synthesis of recommendations, individualized by patient factors, can enhance pediatric polyposis syndrome management.
  • Consolidated guideline tables can serve as practical tools to improve care consistency.
  • Further study is needed to establish the impact of these tools on clinical implementation and patient outcomes.
Abstract

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: